CN Patent

CN114746412A — Kd-025的新晶型及其制备方法

Assigned to Sunshine Lake Pharma Co Ltd · Expires 2022-07-12 · 4y expired

What this patent protects

提供了KD‑025的多种晶型及其制备方法。所述KD‑025多种晶型为晶型N1‑晶型N15，还提供了KD‑025的无定型及其制备方法。所述晶型N1、晶型N2及晶型N15均具有较好的溶解性或稳定性，有利于储存、转移、生产工艺中操作，适于制备成制剂。

USPTO Abstract

提供了KD‑025的多种晶型及其制备方法。所述KD‑025多种晶型为晶型N1‑晶型N15，还提供了KD‑025的无定型及其制备方法。所述晶型N1、晶型N2及晶型N15均具有较好的溶解性或稳定性，有利于储存、转移、生产工艺中操作，适于制备成制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN114746412A
Jurisdiction
CN
Classification
—
Expires
2022-07-12
Drug substance claim
No
Drug product claim
No
Assignee
Sunshine Lake Pharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.